Medication Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Medication stocks.

Medication Stocks Recent News

Date Stock Title
May 9 CPRX Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2024 Earnings Call Transcript
May 9 ALZN Alzamend Neuro enters private placement of up to $25M
May 9 ALZN EXCLUSIVE: Alzamend Neuro To Raise Up To $25M Via Private Placement Of Preferred Shares
May 9 ALZN Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million
May 9 ACAD ACADIA Pharmaceuticals Inc (ACAD) (Q1 2024) Earnings Call Transcript Highlights: Robust Revenue ...
May 9 ACAD ACADIA Pharmaceuticals Inc. (ACAD) Q1 2024 Earnings Call Transcript
May 9 ACAD ACADIA Pharmaceuticals Inc. 2024 Q1 - Results - Earnings Call Presentation
May 8 ACAD Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates
May 8 CPRX Catalyst Pharmaceuticals Non-GAAP EPS of $0.38 beats by $0.08, revenue of $98.44M misses by $0.33M
May 8 CPRX Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
May 8 ACAD Acadia Pharma GAAP EPS of $0.10 beats by $0.05, revenue of $205.83M misses by $2.75M
May 8 ACAD Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
May 8 ABCL AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript
May 8 ABCL Q1 2024 Abcellera Biologics Inc Earnings Call
May 8 ABCL AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript
May 8 ABCL AbCellera Biologics Inc. (ABCL) Q1 2024 Earnings Call Transcript
May 7 ABCL AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates
May 7 ABCL AbCellera Biologics Inc (ABCL) Q1 2024 Earnings: Misses Revenue and Net Loss Estimates
May 7 ACAD Acadia Pharma Q1 2024 Earnings Preview
May 7 CPRX Catalyst Pharmaceuticals Q1 2024 Earnings Preview
Medication

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Drugs are classified in various ways. One of the key divisions is by level of control, which distinguishes prescription drugs (those that a pharmacist dispenses only on the order of a physician, physician assistant, or qualified nurse) from over-the-counter drugs (those that consumers can order for themselves). Another key distinction is between traditional small-molecule drugs, usually derived from chemical synthesis, and biopharmaceuticals, which include recombinant proteins, vaccines, blood products used therapeutically (such as IVIG), gene therapy, monoclonal antibodies and cell therapy (for instance, stem-cell therapies). Other ways to classify medicines are by mode of action, route of administration, biological system affected, or therapeutic effects. An elaborate and widely used classification system is the Anatomical Therapeutic Chemical Classification System (ATC system). The World Health Organization keeps a list of essential medicines.
Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions, drug pricing. Controversies have arisen over drug pricing and disposal of used drugs.

Browse All Tags